Engaging & treating young court referred marijuana users

虽然大量的人寻求治疗，特别是大麻依赖的主要问题，很少有人知道有效的策略来治疗这一人群。被法院系统转介接受治疗的年轻成年大麻使用者的特点是在标准门诊方法中的保留和结果较差。针对这一人群并解决其低水平的动机和促进治疗参与可能是早期干预具有发展为更严重药物使用风险和相关法律的问题的人群的有效策略。动机增强疗法，旨在促进动机的变化，在这个高度矛盾的群体，和应急管理，旨在促进治疗的保留和禁欲，是有前途的战略，因为他们的高水平的经验支持，在其他物质滥用人群和他们的人口适合这里的目标。在这项研究中，150名由缓刑监督官推荐的年轻人将被随机分配，使用随机化，四个条件之一：（1）标准心理教育药物咨询，（2）应急管理加药物咨询，（3）动机增强疗法（MET），（4）应急管理加MET。主要结果将是保留治疗，减少大麻的使用，并诱导长期治疗。研究治疗将持续8周，并将按个体给予受试者。研究治疗停止后1、3、6、9和12个月的随访将评估治疗效果的持久性和/或延迟出现。

Although large numbers of individuals seek treatment specifically for a principal problem of marijuana dependence, little is known about effective strategies to treat this population. Young adult marijuana users who have been referred by the court system for treatment are characterized by poor retention and outcome in standard outpatient approaches. Targeting this population and addressing their low level of motivation and facilitating treatment engagement may be an effective strategy for early intervention with a population at risk for progression to more severe drug use and associated legal problems. Motivational Enhancement Therapy, directed to fostering motivation for change in this highly ambivalent group, and Contingency Management, directed to foster treatment retention and abstinence, are promising strategies, given their high level of empirical support in other substance-abusing populations and their suitability of the population targeted here. In this study 150 young adults referred by their probation officers for evaluation and treatment of marijuana use will be randomly assigned, using randomization, one of four conditions: (1) standard psychoeducational drug counseling, (2) contingency management plus drug counseling, (3) Motivational Enhancement Therapy (MET), and (4) Contingency Management plus MET. Primary outcomes will be retention in treatment, reduction in marijuana use, and induction to long-term treatment. Study treatments will last 8 we4eks and will be delivered to subjects on an individual basis. Follow-ups at 1,3,6,9 and 12 months after cessation of study treatment will assess the durability and/or delayed emergence of treatment effects.